"Generation 9/11": Canadian Muslim Youth Negotiating Nationalist and Sexual Subjectivities

While much attention has been given to the impact on adult Muslims religious identities in the post-9/11 era, little research has been conducted on young Muslims who have grown up in this period. Moreover, the limited research on Muslim youths identity tends to focus almost exclusively on male aggression and female piety. In this dissertation, I argue that the repetition of these themes in both scholarly research and mainstream media serves to narrow an understanding of young Muslims identities, and functions to perpetuate stereotyped notions of young Muslims. I also argue that sexuality is hegemonically employed in North American national ideologies to construct Muslim sexuality as inferior to non-Muslim sexuality; however, until now, researchers have yet to examine its impact on young Muslims sexual subjectivities. I situate my study in the context of national ideology and particularly the shifts taking place in the post-9/11 context that underpin notions of belonging and citizenship. The idea of the nation includes regulations and restrictions for sexual crossingsthat is, good citizens should not have sex with the enemy Other (Nagel, 2003: 141-42). National belonging thus entails controlling the sexual practices of national members and defining acceptable sexual coupling. Accordingly, because terrorist-enemy constructions are frequently linked to Muslim identity, my study examines how this sexually racialized structuring affects young Canadian Muslims perceptions of national belonging and citizenship. I argue that these interrelated constructions of Muslim identity and national belonging have an impact on young Canadian Muslims sexual subjectivities and their perceptions of appropriate sexual coupling within a national context. Hence, this study simultaneously illuminates the links between Muslim sexual identity and perspectives of national belonging as well as stresses young Muslim identities as an under-researched area of Canadian identity politics

State of the Research on Artificial Intelligence Based Apps for Post-Secondary Students with Disabilities

We conducted a general Google search and a scoping review of various types of artificial intelligence (AI) based technology – mobile, web-based, software, hardware – used by college and university students to do schoolwork. The main findings indicate that (1) there is no generally agreed upon definition of AI, and (2) there is a huge discrepancy between the popular press articles that are behind the AI hype and the scientific literature. The popular press provides an overview of the AI tools available to students with disabilities and discusses how students can use these tools. The scientific literature is primarily devoted to tool development and has poor methodology. We conclude that the potential of AI for post-secondary students with disabilities is enormous, but that informed research about these tools is scant, with a profound lack of demonstrated scalability. Research needs to address “real-world” uses of AI-based tools by post-secondary students with disabilities

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Objective: To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of Rheumatology (ACR) and EULAR. Methods: This international multidisciplinary initiative included 4 phases: 1) Phase I, criteria generation by surveys and literature review; 2) Phase II, criteria reduction by modified Delphi and nominal group technique exercises; 3) Phase III, criteria definition, further reduction with the guidance of real-world patient scenarios, and weighting via consensus-based multicriteria decision analysis, and threshold identification; and 4) Phase IV, validation using independent adjudicators' consensus as the gold standard. Results: The 2023 ACR/EULAR APS classification criteria include an entry criterion of at least one positive antiphospholipid antibody (aPL) test within 3 years of identification of an aPL-associated clinical criterion, followed by additive weighted criteria (score range 1-7 points each) clustered into 6 clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular, obstetric, cardiac valve, and hematologic) and 2 laboratory domains (lupus anticoagulant functional coagulation assays, and solid-phase enzyme-linked immunosorbent assays for IgG/IgM anticardiolipin and/or IgG/IgM anti-β2-glycoprotein I antibodies). Patients accumulating at least 3 points each from the clinical and laboratory domains are classified as having APS. In the validation cohort, the new APS criteria versus the 2006 revised Sapporo classification criteria had a specificity of 99% versus 86%, and a sensitivity of 84% versus 99%. Conclusion: These new ACR/EULAR APS classification criteria were developed using rigorous methodology with multidisciplinary international input. Hierarchically clustered, weighted, and risk-stratified criteria reflect the current thinking about APS, providing high specificity and a strong foundation for future APS research.</p

2023 ACR/EULAR antiphospholipid syndrome classification criteria

International audienceObjective. To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of Rheumatology (ACR) and EULAR. Methods This international multidisciplinary initiative included four phases: (1) Phase I, criteria generation by surveys and literature review; (2) Phase II, criteria reduction by modified Delphi and nominal group technique exercises; (3) Phase III, criteria definition, further reduction with the guidance of real-world patient scenarios, and weighting via consensus-based multicriteria decision analysis, and threshold identification; and (4) Phase IV, validation using independent adjudicators’ consensus as the gold standard. Results. The 2023 ACR/EULAR APS classification criteria include an entry criterion of at least one positive antiphospholipid antibody (aPL) test within 3 years of identification of an aPL-associated clinical criterion, followed by additive weighted criteria (score range 1–7 points each) clustered into six clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular, obstetric, cardiac valve, and hematologic) and two laboratory domains (lupus anticoagulant functional coagulation assays, and solid-phase enzyme-linked immunosorbent assays for IgG/IgM anticardiolipin and/or IgG/IgM anti–β 2 -glycoprotein I antibodies). Patients accumulating at least three points each from the clinical and laboratory domains are classified as having APS. In the validation cohort, the new APS criteria vs the 2006 revised Sapporo classification criteria had a specificity of 99% vs 86%, and a sensitivity of 84% vs 99%. Conclusion. These new ACR/EULAR APS classification criteria were developed using rigorous methodology with multidisciplinary international input. Hierarchically clustered, weighted, and risk-stratified criteria reflect the current thinking about APS, providing high specificity and a strong foundation for future APS research